wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50271158-DA34C39A-BED6-4CBA-8916-4F567BB13964
Q50271158-DA34C39A-BED6-4CBA-8916-4F567BB13964
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50271158-DA34C39A-BED6-4CBA-8916-4F567BB13964
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.
P356
Q50271158-DA34C39A-BED6-4CBA-8916-4F567BB13964
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50271158-DA34C39A-BED6-4CBA-8916-4F567BB13964
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
49525df2e58bf3548a5dcbfa0a0341213eb8ee76
P356
10.1093/ANNONC/MDX343
http://www.w3.org/2001/XMLSchema#string
P356
MDX343